UnitedHealth Group Incorporated (UNH) Shares Bought by Veritas Investment Management LLP

Veritas Investment Management LLP grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 444,471 shares of the healthcare conglomerate’s stock after buying an additional 21,539 shares during the quarter. UnitedHealth Group accounts for 12.0% of Veritas Investment Management LLP’s investment portfolio, making the stock its largest position. Veritas Investment Management LLP’s holdings in UnitedHealth Group were worth $82,392,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. Spectrum Management Group Inc. increased its position in shares of UnitedHealth Group by 16.7% in the second quarter. Spectrum Management Group Inc. now owns 2,765 shares of the healthcare conglomerate’s stock valued at $513,000 after buying an additional 395 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its position in shares of UnitedHealth Group by 26.1% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 574,874 shares of the healthcare conglomerate’s stock valued at $106,593,000 after buying an additional 118,850 shares in the last quarter. Calamos Advisors LLC increased its position in shares of UnitedHealth Group by 0.3% in the second quarter. Calamos Advisors LLC now owns 532,276 shares of the healthcare conglomerate’s stock valued at $98,695,000 after buying an additional 1,482 shares in the last quarter. Calamos Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.5% in the second quarter. Calamos Wealth Management LLC now owns 51,777 shares of the healthcare conglomerate’s stock valued at $9,600,000 after buying an additional 238 shares in the last quarter. Finally, Meiji Yasuda Life Insurance Co increased its position in shares of UnitedHealth Group by 7.9% in the second quarter. Meiji Yasuda Life Insurance Co now owns 32,951 shares of the healthcare conglomerate’s stock valued at $6,110,000 after buying an additional 2,400 shares in the last quarter. Institutional investors and hedge funds own 86.17% of the company’s stock.

A number of research firms have recently commented on UNH. Royal Bank Of Canada restated a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 20th. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 price objective (up from $190.00) on shares of UnitedHealth Group in a research report on Saturday, July 22nd. Citigroup Inc. boosted their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research report on Tuesday, August 1st. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $216.65.

WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Veritas Investment Management LLP” was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/11/11/unitedhealth-group-incorporated-unh-shares-bought-by-veritas-investment-management-llp.html.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the sale, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 72,149 shares of company stock worth $14,212,342. 0.89% of the stock is owned by company insiders.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.07 on Friday. UnitedHealth Group Incorporated has a 12 month low of $146.01 and a 12 month high of $213.93. The company has a current ratio of 0.70, a quick ratio of 0.72 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $204,080.00, a PE ratio of 21.95, a P/E/G ratio of 1.56 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the prior year, the business earned $2.17 EPS. UnitedHealth Group’s revenue was up 8.7% on a year-over-year basis. analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.09%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply